📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pharmion

1.1 - Company Overview

Pharmion Logo

Pharmion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of products for the treatment of hematology and oncology patients, focused on acquisition, development, and commercialization. Global biotech partnering with scientific and clinical advisors to identify and develop products for hematology and oncology markets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pharmion

Eagle Pharmaceuticals Logo

Eagle Pharmaceuticals

HQ: United States Website
  • Description: Provider of injectable pharmaceuticals for critical care and oncology, including PEMFEXY (pemetrexed) for nonsquamous NSCLC and malignant pleural mesothelioma; BARHEMSYS (amisulpride) for prevention and treatment of postoperative nausea and vomiting; BYFAVO (remimazolam) for procedural sedation; RYANODEX (dantrolene) for malignant hyperthermia; BELRAPZO and BENDEKA (bendamustine) for CLL and indolent B-cell NHL.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eagle Pharmaceuticals company profile →
Cyclo Therapeutics Logo

Cyclo Therapeutics

HQ: United States Website
  • Description: Provider of cyclodextrin-based therapeutics, including Trappsol® Cyclo™, a proprietary hydroxypropyl beta cyclodextrin formulation in clinical trials for Niemann-Pick Disease Type C1 and in a Phase 2b trial for early Alzheimer’s disease, leveraging data from an Expanded Access program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cyclo Therapeutics company profile →
Immunex Logo

Immunex

HQ: United States Website
  • Description: Provider of therapeutic products for cancer, infectious diseases, and autoimmune disorders. Develops, manufactures, and markets treatments including Enbrel for rheumatoid arthritis and Novantrone for acute nonlymphocytic leukemia and pain associated with prostate cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immunex company profile →
G7 Therapeutics Logo

G7 Therapeutics

HQ: Switzerland Website
  • Description: Provider of proprietary approaches to stabilize G protein-coupled receptors (GPCRs), enabling novel structure-based drug development for designing highly selective small molecules or biologics targeting GPCRs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full G7 Therapeutics company profile →
FibroGen Logo

FibroGen

HQ: United States Website
  • Description: Provider of novel therapeutics leveraging CTGF and HIF biology, including Roxadustat, an oral small molecule for anemia in CKD patients on or off dialysis; Pamrevlumab, a human monoclonal antibody in development for metastatic and locally advanced pancreatic cancer and DMD; and FG-3246, a first-in-class fully human ADC targeting CD46 for metastatic castration-resistant prostate cancer and other tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full FibroGen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pharmion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pharmion

2.2 - Growth funds investing in similar companies to Pharmion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pharmion

4.2 - Public trading comparable groups for Pharmion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pharmion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pharmion

What does Pharmion do?

Pharmion is a provider of products for the treatment of hematology and oncology patients, focused on acquisition, development, and commercialization. Global biotech partnering with scientific and clinical advisors to identify and develop products for hematology and oncology markets.

Who are Pharmion's competitors?

Pharmion's competitors and similar companies include Eagle Pharmaceuticals, Cyclo Therapeutics, Immunex, G7 Therapeutics, and FibroGen.

Where is Pharmion headquartered?

Pharmion is headquartered in United States.

How many employees does Pharmion have?

Pharmion has 1,000 employees 🔒.

When was Pharmion founded?

Pharmion was founded in 2010 🔒.

What sector and industry vertical is Pharmion in?

Pharmion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pharmion

Who are the top strategic acquirers in Pharmion's sector and industry

Top strategic M&A buyers and acquirers in Pharmion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pharmion?

Top strategic M&A buyers groups and sectors for Pharmion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pharmion's sector and industry vertical

Which are the top PE firms investing in Pharmion's sector and industry vertical?

Top PE firms investing in Pharmion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pharmion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pharmion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pharmion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pharmion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pharmion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pharmion?

The key public trading comparables and valuation benchmarks for Pharmion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pharmion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pharmion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pharmion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pharmion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pharmion's' sector and industry vertical?

Access recent funding rounds and capital raises in Pharmion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pharmion